Calcium, a vital mineral, plays a critical role in maintaining skeletal health. Its importance extends beyond the formation of healthy bones and teeth, as it is also essential for muscle contraction, blood clotting, and nerve function. This article aims to elucidate the significant role of calcium in bone metabolism and its implications for clinical practice.
Approximately 99% of the body's calcium is stored in the bones and teeth, where it supports their structure and functionality. Bone metabolism is a continuous process of bone formation and resorption, which is regulated by calcium. The balance between these processes is essential for maintaining bone health. Any disruption in this balance can lead to bone diseases such as osteoporosis and rickets.
Calcium homeostasis, the balance of calcium levels in the body, is primarily regulated by three hormones: parathyroid hormone, calcitonin, and vitamin D. These hormones work together to control the absorption, excretion, and storage of calcium. Any disruption in the function of these hormones can lead to abnormal bone metabolism and subsequently, bone disease.
Understanding the role of calcium in bone metabolism is crucial for clinicians. It aids in the diagnosis and treatment of bone diseases and helps guide dietary recommendations. Moreover, it can also influence the development of therapeutic strategies for diseases related to calcium imbalance. Therefore, a comprehensive understanding of calcium metabolism is essential for optimal patient care.
In conclusion, calcium plays a pivotal role in bone metabolism and overall health. Its importance extends beyond bone health, influencing various physiological processes. A profound understanding of calcium metabolism can significantly enhance clinical practice, contributing to improved patient outcomes and the development of effective therapeutic strategies.
1.
What is a "cancer vaccine" and is it the same as a COVID vaccine?
2.
Advances in "next generation" photoactive cancer therapy
3.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
4.
Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis
5.
FDA Approves New Bladder Cancer First-Line Standard of Care.
1.
Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec
2.
The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v
3.
The latest Hematocrit: An Overview of Red Blood Cell Health
4.
Contemporary Trends in Oncology and Patient Outcomes
5.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation